Past Winners

Inge Jacobs (KU Leuven)

The role of eosinophils in intestinal inflammation and fibrosis

Laure Maes (U Gent)

Establishing a multi-organ microphysiological system to advance gut-brain communication research and development

Sara Deleu (KU Leuven)

Explaining the sharp demarcation in UC patients and identifying potential new therapeutic targets

Sophie Vieujean (Translational Gastroenterology, CHU, Liège GIGA-Research) 

Involvement of intestinal epithelium in fibrosis initiation and worsening in Crohn’s disease

Sophie Van Welden (U Gent)

Prolyl hydroxylase 1, a promising therapeutic target for colitis-associated cancer

Liselotte Fierens  (KU Leuven)

Quality of care for patients with Inflammatory bowel diseases

Kathleen Machiels and Clara Caenepeel (KU Leuven)

Predictive potential and role of microbiota in the efficacy of biological treatment and development of paradoxical adverse events in patients with inflammatory bowel disease

Ho-Su Lee (KU Leuven)

Familial aggregation in Inflammatory Bowel Disease: a next-generation sequencing study

Marie Truyens (U Gent)

The etiopathogenesis of persistent fatigue in patients with inflammatory bowel disease

Publication reference: Effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease: a randomized controlled trial - Gastroenterology (gastrojournal.org)

Kaline Arnauts  (KU Leuven)

The effect of microbiota on intestinal epithelial cells in ulcerative colitis

Simon Bos (U Gent)

Early detection and longitudinal monitoring of intestinal fibrosis in patients with crohn’s disease

Lucas Wauters (KU Leuven)

Unravelling the small bowel microbiome in Crohn’s disease

Sare Verstockt   (KU Leuven)

Molecular profiling of early events in IBD pathogenesis to find markers for early diagnosis

Wiebe Van Hove / Magalie de Bruyn  (KU Leuven)                  

Primary intestinal epithelial cells: a personalized tool for functional characterization of IBD-associated pathways

Cara De Galan (U Gent)

Predictive factors for the clinical response to vedolizumab

Joao Sabino (Leuven)
Food influence on the Intestinal microbioTa trial (FIT trial)
 
Claire Liefferinckx (Bruxelles)
Identification of Genetic variants regulating gEne hubs in the cOntrol of specific and genericmodules across context-dependent activation of Immune Cells in healthy subjects: Understandingthe genetic architecture Of Disease sEverity in IBD (GEOCODE IBD project)
 
Bram Verstockt (Leuven)
Predicting outcome of inflammatory bowel diseases: creating opportunities for personalized medicine

Hindryckx Pieter  (UGent)
The contribution of hypoxia to the pathogenesis and the course of inflammatory bowel disease: defining the window for therapeutic intervention
 
Vancamelbeke Maaike (KU Leuven)
The Role of the Intestinal Epithelial Barrier in the Pathophysiology of Inflammatory Bowel Diseases

Ingrid Arijs (Leuven)
Study of the effect of vedolizumab therapy on colonic mucosal gene expression in patients with ulcerative colitis

Manuel Nobel (Leuven)
Intestinal stem cells - microbiota interactions in inflammatory bowel diseases

Debby Laukens (Gent)
The therapeutic use of anti-metallothionein antibodies in IBD: bench-to-bedside

Dominiek Staelens and Kris Nys (Leuven)
Crohn's susceptibility genes in innate immunity, ER stress and autophagy: from genetics to personalized medicine